Press Releases Archives - Page 10 of 103 - Lupin

BSE 2300.00 NSE 2307.90

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2300.00 NSE 2307.90

Lupin Digital Health Partners with Medicover Hospitals for Comprehensive Post-Discharge Cardiac Care

December 16, 2024

Lupin Acquires 3 Trademarks from Boehringer Ingelheim to Strengthen Diabetes Portfolio

December 13, 2024

Lupin Receives Tentative Approval from U.S. FDA for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension

December 6, 2024

Lupin’s R&D Facility in Pune Awarded LEED Platinum Certification

December 5, 2024

Lupin Receives Tentative Approval from U.S. FDA for Sitagliptin and Metformin Hydrochloride Tablets

November 28, 2024

Lupin’s ESG Score Rises to 76 in S&P Global ESG Ratings

November 22, 2024

Lupin and NAPCON Hosts a Walkathon ‘A Step Towards HealThy Lungs’ for COPD Awareness

November 20, 2024

Lupin Launches Bumetanide Injection, USP in the United States

November 19, 2024

Lupin Receives Approval from U.S. FDA for Mixed Salts of a Single-Entity Amphetamine Extended-Release Capsules

November 19, 2024

Lupin’s Humrahi Diabetes Support Program Expands to Include Heart Health

November 18, 2024

1 2 … 9 10 11 … 102 103

Search

Hit enter to search or ESC to close